Product NewsDrug discovery > Clinical Development GemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
Product NewsLife Sciences Sigma Launches Human Plasma Depletion Technology for Proteomics and Human Disease Biomarker Discovery
Product NewsLife Sciences Electrophoretic fingerprinting of HIV/AIDS virus – another first for the Malvern Zetasizer Nano
Product NewsLife Sciences SYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
